Department of Defense (DoD) Post-Traumatic Stress Disorder Investigator-Initiated Research Award

Current Closing Date for Applications:
Oct 12, 2007


The Post-Traumatic Stress Disorder (PTSD) Investigator-Initiated Research Award supports basic and clinically oriented research that will (1) result in substantial improvements over today’s approach to the treatment and clinical management of PTSD, (2) facilitate the development of novel preventive measures, and (3) enhance the quality of life of persons with PTSD. Proposals must include preliminary data relevant to PTSD research and the proposed project. In addition, if appropriate, a clear statistical plan of analysis should be included. Proposals containing clinical trials or clinical research are appropriate for this award. It is envisioned that access to Active Duty, National Guard, Reserve troops, and/or Military patient populations will be coordinated through a centralized DOD coordinating office, to be established prior to final recommendation of proposals for funding. Research proposal submissions that include Active duty, National Guard, Reserve troops, and/or Military patient populations must be accompanied by a Clinical Protocol (Appendix 7). Those proposals that score favorably during the scientific peer review and require access to Military patient populations will be forwarded to the centralized DOD coordinating office for consideration and review for availability and access to military patient populations prior to being recommended for funding. Please do not contact any Commander of Active duty, National Guard, Reserve troops and/or Military patient populations at this time or during preparation of your proposal submission. However we highly encourage you to collaborate with military researchers and clinicians. Access to Military populations will be handled by the coordinating center only. If selected for funding you will be provided guidance on how to obtain access to the appropriate population. Submissions that propose to recruit patients from Department of Veterans Affairs (VA) Medical Centers or use information from VA data systems must include an investigator with a VA appointment. This individual may be the principal investigator for the entire proposal or a VA collaborator willing to assume the role of principal VA investigator for the VA component of the proposal. Currently, there is a very limited ability to conduct human research in the CENTCOM Area of Responsibility. At present, this capability exists solely within select elements of the Multi-National Corps Iraq (MNC-I). There is no ability to conduct human research in Afghanistan at present. All research conducted within MNC-I must be in collaboration with an in theatre military investigator, undergo an in theatre review, and be approved by the MNC-I Command and the MNC-I designated Institutional Review Board. Given the constraints of wartime operations, investigators without an ongoing collaboration with a military investigator should strongly consider alternatives to the conduct of research in the wartime theatre. Note: DOD-supported human subjects research can only be conducted by institutions (to include those in theatre) with approved Federal Assurances of Compliance from Human Research Protection.

If you have difficulty accessing the full announcement electronically, please contact:
Pamela L. Fisher Grants Officer Phone 301-619-2805 Contracting/Grant Officer

Department of Defense (DoD) Traumatic Brain Injury (TBI) Concept Award

Current Closing Date for Applications:
Aug 23, 2007


The Traumatic Brain Injury (TBI) Concept Award supports the exploration of a new idea or innovative concept that could give rise to a testable hypothesis. Presentation of preliminary data is not required and is not consistent with the intent of this award mechanism. However, a rationale for the work must be provided. These awards provide PIs with the opportunity to pursue serendipitous observations. Proposals must describe how the new idea will enhance existing knowledge of traumatic brain injury or create an entirely new avenue for investigation. Research completed through a Concept Award may provide sufficient preliminary data to enable the PI to prepare a proposal for future research. The key initiative of the Concept Award is to spark new ideas, innovative technologies, and ground-breaking concepts that will drive the field of TBI research forward. Concepts that incorporate multiple disciplines are encouraged, as are research proposals involving collaborations among academia, Historically Black Colleges and Universities/Minority Institutions, industry, the military Services, the Department of Veterans Affairs, and other Federal Government agencies.

If you have difficulty accessing the full announcement electronically, please contact:
Pamela L. Fisher Grants Officer Phone 301-619-2805 Contracting/Grant Officer

Advanced Tools and Technologies for Deep Brain Stimulation in Movement Disorders - SBIR (R43/R44)

Current Closing Date for Applications:
Multiple Receipt Dates - See Link to Full Announcement for details


This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for projects to design and develop advanced tools and technologies that will lead to improved clinical treatment for Deep Brain Stimulation (DBS) patients. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-07-395, that solicits applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. -Funds Available and Anticipated Number of Awards. For this funding opportunity, budgets up to $250,000 total costs per year and time periods up to 2 years for Phase I may be requested. Budgets up to $500,000 total costs per year and up to 3 years may be requested for Phase II. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

Link to Full Announcement
http://grants.nih.gov/grants/guide/pa-files/PA-07-396.html

If you have difficulty accessing the full announcement electronically, please contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOVIf you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Synopsis Modification History
The following files represent the modifications to this synopsis with the changes noted within the documents. The list of files is arranged from newest to oldest with the newest file representing the current synopsis. Changed sections from the previous document are shown in a light grey background.

Original Synopsis
Jul 12, 2007

Understanding and Treating Generalized and Focal Dystonias - R01 and R21

Current Closing Date for Applications:
Multiple Receipt Dates - See Link to Full Announcement for details

The National Institute of Neurological Disorders and Stroke (NINDS), National Institute of Child Health and Human Development (NICHD), National Institute on Deafness and Other Communication Disorders (NIDCD), National Institute of Environmental Health Sciences (NIEHS), in conjunction with the Dystonia Medical Research Foundation (DMRF) and the Bachmann-Strauss Dystonia and Parkinson Foundation, Inc., invite research grant applications aimed at understanding or treating generalized and focal dystonias. The aim of this FOA is to encourage basic, translational and clinical studies, to determine the patho-physiology of dystonia, to stimulate the development of basic and translational resources to further dystonia research, to accelerate research into promising therapeutic approaches for dystonia, and to stimulate progress in dystonia research through encouraging and facilitating interdisciplinary interactions. -Mechanism of Support. This funding opportunity will utilize the NIH R01 mechanism, and runs in parallel with another FOA of identical scientific scope (PA-07-398) that solicit applications under the NIH Exploratory/Developmental grant mechanism (R21). -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

Link to Full Announcement
http://grants.nih.gov/grants/guide/pa-files/PA-07-397.html

If you have difficulty accessing the full announcement electronically, please contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOVIf you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Advanced Tools and Technologies for Deep Brain Stimulation in Movement Disorders - STTR (R41/R42)

Current Closing Date for Applications:
Multiple Receipt Dates - See Link to Full Announcement for details

This Funding Opportunity Announcement (FOA) invites Small Business Technology Transfer Research (STTR) grant applications from small business concerns (SBCs) for projects to design and develop advanced tools and technologies that will lead to improved clinical treatment for Deep Brain Stimulation (DBS) patients. -Mechanism of Support. This FOA will utilize the STTR (R41/R42) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-07-396, that solicits applications under the Small Business Innovation Research (SBIR) (R43/R44) grant mechanisms. -Funds Available and Anticipated Number of Awards. For this funding opportunity, budgets up to $250,000 total costs per year and time periods up to 2 years for Phase I may be requested. Budgets up to $500,000 total costs per year and up to 3 years may be requested for Phase II. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

Link to Full Announcement
http://grants.nih.gov/grants/guide/pa-files/PA-07-395.html

If you have difficulty accessing the full announcement electronically, please contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOVIf you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Synopsis Modification History
The following files represent the modifications to this synopsis with the changes noted within the documents. The list of files is arranged from newest to oldest with the newest file representing the current synopsis. Changed sections from the previous document are shown in a light grey background.

Original Synopsis
Jul 12, 2007

Alzheimer's Disease Demonstration Grants to States (ADDGS) Program

Administration on Aging

Current Closing Date for Applications:
Aug 28, 2007 See link to full announcement for details

The statutory authority for grant awards for the Alzheimer's Disease Demonstration Grants to States program is contained in Sec. 398 of the Public Health Service Act (P.L. 78-410; 42 U.S.C. 280c-3). It was amended by the Home Health Care and Alzheimer's Disease Amendments of 1990 (PL 101-557) and by the Health Professions Education Partnerships Act of 1998 (PL 105-392). Section 398 of the Public Health Service Act (42 U.S.C. 398 et seq.), as amended, requires that grantees provide a 25% match (cash or in-kind). Waivers to this match requirement are not allowed. AoA plans to fund approximately six (6) to eight (8) new cooperative agreements nationwide through this competition. The cooperative agreements will be funded at a federal share of up to $400,000, with most awardees expected to receive $250,000 for a project period of eighteen months (contingent on the availability of funds.) If the applicant requests more than $250,000, up to the maximum award amount of $400,000, the proposal must clearly detail the reason(s) for requesting funds above $250,000 (i.e., the research project to be implemented does not have the necessary tools, such as training manuals, to facilitate project start-up; the potential number of people affected and the degree of enduring change in the state's system of long term care for people with ADRD or their caregivers; and/or the measurement tools required to ensure the fidelity of the proposed project are substantial.) A total of $1,700,000 has been allocated for these cooperative agreements. Projects carried out using ADDGS grant funds focus on: 1) Coordinating the development and operation with public and private organizations of diagnostic, treatment, care services provided within the State to individuals with Alzheimer's disease and related dementias and to the families and care providers of such individuals; 2) Providing ADDGS-statutorily defined direct services, which include, and are limited to, home health care, personal care, day care, companion services, short-term care in health facilities, and other respite care to individuals with Alzheimer's disease and related dementias who are living in single family homes or congregate settings. At least 50% of the total federal grant funds are to be spent on providing these direct services and no more than 10% of the total project funds can be spent on administrative costs; 3) Improving the access of such individuals to home-based or community-based long-term care services, particularly such individuals who are members of racial or ethnic minority groups, who have limited proficiency in speaking the English language, or who live in rural areas; and 4) Providing to health care providers, to individuals with Alzheimer's disease and related dementias, to the families of such individuals, to organizations established for such individuals and such families, and to the general public, information with respect to: (A) diagnostic services, treatment services, and related services available to such individuals and to the families of such individuals; (B) sources of assistance in obtaining such services, including assistance under entitlement programs; and (C) the legal rights of such individuals and such families. Alzheimer's disease (AD) is a progressive, degenerative disease of the brain, and the most common form of dementia. Discovered and described in 1906 by Dr. Alois Alzheimer, AD now affects approximately 5 million Americans. Unless a cure or prevention is found, it is estimated that the number of Americans with Alzheimer's will climb to 14 million by the middle of the next century. Although AD is not a normal part of aging, one in 10 persons over 65 and nearly half of those over 85 may have Alzheimer's disease. A small percentage of people in their 30s and 40s also develop the disease. Although AD eventually results in death, the disease can progress for years. A person with AD lives an average of 8 years, but can live as many as 20 years or more from the onset of symptoms. To focus attention on this need, to encourage states to develop models of assistance for persons with Alzheimer's disease and related dementias (ADRD), and to encourage close coordination and incorporation of those services into the broader home and community based care system, Congress funded the Alzheimer's Disease Demonstration Grants to States (ADDGS) program in 1991. Congress transferred the administration of the program to the AoA in 1998, in an effort to ensure coordination with other programs for older Americans. To date, the ADDGS program has proven successful in targeting service and system development to traditionally underserved populations, including ethnic minorities, low-income and rural families coping with Alzheimer's disease.

Link to Full Announcement
http://AoA.gov

If you have difficulty accessing the full announcement electronically, please contact:
Lori StalbaumLori.Stalbaum@aoa.hhs.govLori Stalbaum

Defense University Research Instrumentation Program (DURIP) - for Proposal Submission to Navy

Current Closing Date for Applications:
Aug 21, 2007

The Department of Defense (DoD) announces the Fiscal Year 2008 Defense University Research Instrumentation Program (DURIP), a part of the University Research Initiative (URI). DURIP is designed to improve the capabilities of U.S. institutions of higher education (hereafter referred to as “universities”) to conduct research and to educate scientists and engineers in areas important to national defense, by providing funds for the acquisition of research equipment. The research areas of interest for the administering agencies are available on-line at the following addresses: Army Research Office: http://www.aro.army.mil/ (select “For the Researcher” and then “Funding Opportunities”) See BAA W911NF-07-R-0003 Office of Naval Research: http://www.onr.navy.mil/ (select “ONR Science and Technology Departments”) (Refer questions about appropriate program managers to contact to Dr. Bill Lukens, 703-696-4668) Air Force Office of Scientific Research: http://www.afosr.af.mil/ (select “Research Areas”) For detailed information regarding technical goals, potential proposers are advised to refer to the announcements cited above and may contact DoD program managers listed therein to explore mutual interest before submitting proposals. A proposal may be submitted to more than one agency; however, only one award will be given. A central purpose of the DURIP is to provide equipment to enhance research-related education. Therefore proposals must address the impact of the equipment on the institution’s ability to educate students, through research, in disciplines important to DoD missions. This announcement seeks proposals to purchase instrumentation in support of research areas of interest to the DoD, including areas of research supported by the administering agencies.

Link to Full Announcement
Link to All ONR BAA's

If you have difficulty accessing the full announcement electronically, please contact:
Kristin Fuller Contract Specialist Phone 703-696-4591 GRANTS.GOV QUESTIONS ONLY

Joint DMS/NIGMS Initiative to Support Research in the Area of Mathematical Biology

Current Closing Date for Applications: Oct 01, 2007

The Division of Mathematical Sciences in the Directorate for Mathematical and Physical Sciences and the National Institute of General Medical Sciences at the National Institutes of Health plan to support research in mathematics and statistics related to mathematical biology research. Both agencies recognize the need and urgency for additional research at the boundary between the mathematical sciences and the life sciences. This competition is designed to encourage new collaborations at this interface, as well as to support existing ones.
Link to Full Announcement

NSF Publication 06-607

If you have difficulty accessing the full announcement electronically, please contact: Grants.gov support Grants.gov support

Synopsis Modification History
The following files represent the modifications to this synopsis with the changes noted within the documents. The list of files is arranged from newest to oldest with the newest file representing the current synopsis. Changed sections from the previous document are shown in a light grey background.
Original Synopsis
Sep 15, 2006

Clinical Studies of Safety and Effectiveness of Orphan Products

Original Closing Date for Applications:
Feb 06, 2008 All Applications must be received by the close of business on the establised receipt date. The Application Receipt Date is February 6, 2008.

Background OPD was created to identify and promote the development of orphan products. Orphan products are drugs, biologics, medical devices, and foods for medical purposes that are indicated for a rare disease or condition (that is, one with a prevalence, not incidence, of fewer than 200,000 people in the United States). Diagnostic tests and vaccines will qualify only if the U.S. population of intended use is fewer than 200,000 people a year. Additional information about OPD is available on FDA’s Web site at www.fda.gov/orphan. 2. Program Research Goals The goal of FDA’s OPD grant program is to support the clinical development of products for use in rare diseases or conditions where no current therapy exists or where the product will improve the existing therapy. FDA provides grants for clinical studies on safety and/or effectiveness that will either result in, or substantially contribute to, market approval of these products. Applicants must include in the application’s ‘‘Background and Significance’’ section documentation to support the estimated prevalence of the orphan disease or condition and an explanation of how the proposed study will either help gain product approval or provide essential data needed for product development. All funded studies are subject to the requirements of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 331 et seq.), regulations issued under it, and applicable Department of Health and Human Services (HHS) statutes and regulations. Inclusion of Women And Minorities in Clinical Research Applicants for PHS clinical research grants are encouraged to include minorities and women in study populations so research findings can be of benefit to all people at risk of the disease or condition under study. It is recommended that applicants place special emphasis on including minorities and women in studies of diseases, disorders, and conditions that disproportionately affect them. This policy applies to research subjects of all ages. If women or minorities are excluded or poorly represented in clinical research, the applicant should provide a clear and compelling rationale that shows inclusion is inappropriate. Inclusion of Children as Participants in Clinical Research. FDA regulations at 21 CFR part 50, subpart D contain additional requirements that must be met by IRBs reviewing clinical investigations regulated by FDA and involving children as subjects. FDA is part of HHS; accordingly, the research project grants under this program are supported by HHS, and HHS regulations at 45 CFR part 46, subpart D also apply to research involving children as subjects. Standards for Privacy of Individually Identifiable Health Information HHS issued final modification to the ‘‘Standards for Privacy of Individually Identifiable Health Information,’’ the ‘‘Privacy Rule,’’ on August 14, 2002. The Privacy Rule is a federal regulation under the Health Insurance Portability and Accountability Act (HIPAA) of 1996 that governs the protection of individually identifiable health information, and is administered and enforced by the HHS Office for Civil Rights (OCR). PHS is committed to achieving the health promotion and disease prevention objectives of ‘‘Healthy People 2010,’’ a PHS-led national activity for setting priority areas. This Funding Opportunity Announcement is related to one or more of the priority areas. Potential applicants may obtain a copy of ‘‘Healthy People 2010’’ at http:// www.health.gov/healthypeople. Smoke-Free Workplace The PHS strongly encourages all grant recipients to provide a smoke-free workplace and discourage the use of all tobacco products. In addition, Public Law 103–227, the Pro-Children Act of 1994, prohibits smoking in certain facilities (or in some cases, any portion of a facility) in which regular or routine education, library, day care, health care, or early childhood development services are provided to children. This is consistent with the PHS mission to protect and advance the physical and mental health of the American people.
Link to Full Announcement
http://a257.g.akamaitech.net/7/257/2422/01jan20071800/edocket.access.gpo.gov/2007/pdf/E7-12881.pdf
If you have difficulty accessing the full announcement electronically, please contact:
Marc Pitts Senior Grants Management Specialist Phone 301-827-7162 Marc.Pitts@FDA.HHS.GOV

IMHR 4th Annual Request for Reseach Grant Application

APPLICATION RECEIPT DATE: Application Deadline: September 4, 2007

PURPOSE: The Institute for Mental Health Research invites applications for pilot studies to support basic science and clinical research on mental disorders and mental health.

MECHANISMS OF SUPPORT: Grants of up to $25,000 for individual investigators and $50,000 for collaborative grants will be made, subject to availability of funds. The funding period is for one year. No indirect costs will be paid. ELIGIBILITY: Research performance sites must be in Arizona. Investigators who have received one IMHR grant in the past are eligible to apply for another IMHR grant on a different project; their application must mention the previous grant, its progress to date, and any published works about it. Investigators may receive only two consecutive IMHR grants; after two consecutive grants they must wait one year before applying for another grant.RESEARCH OBJECTIVES: The Institute for Mental Health Research Pilot Study Program is designed to facilitate new research on mental disorders and mental health.

Information obtained from the research should allow for subsequent submission for competitive grant support through other funding agencies or have commercial potential.

Proposals related to IMHR's focus on the understanding, treatment and prevention of mental illness and the promotion and maintenance of mental health from a developmental lifespan perspective--the study of mental illness and health in children, adolescents, adults and later in life--are encouraged. IMHR also encourages, but does not require, the submission of applications for studies of Hispanic and Native American populations.

All proposals must include a preliminary plan and timeline for submission of a competitive grant application to another funding source.The mission of the Institute for Mental Health Research encourages collaboration between institutions. Therefore, in addition to individual grants of $25,000, the Institute will award two $50,000 grants for research that demonstrates collaboration between two or more institutions (e.g., universities or hospitals) within the state of Arizona.Full Application:

1) Completion of the Verification of No Prior Funding form (attached to this announcement or available from IMHR - request at http://www.firedrummarketing.com/servlet/clickercount?clientid=00000203&messageid=00001106&memberid=01322706&sendingid=560FBFB751D5&campaignid=00001106&finaldest=mailto:clagesse@imhr.org).
2) A list of 5 names, addresses, phone numbers, and email addresses of suggested reviewers for the application. The suggested reviewers should not work with the applicant and should, preferably, work out of state.
3) The PHS research grant application instructions and forms (rev. 4/2006) at http://www.firedrummarketing.com/servlet/clickercount?clientid=00000203&messageid=00001106&memberid=01322706&sendingid=560FBFB751D5&campaignid=00001106&finaldest=http://grants.nih.gov/grants/funding/phs398/phs398.html must be used in applying for these funds. Applications must include:
a. Face page/Grant Application (form page 1, and page 1-continued if there are multiple investigators)
b. Description, Performance Sites, and Personnel (form page 2)
c. Table of Contents (form page 3)
d. Detailed Budget (form page 4 – budget is limited to $25,000 for an individual grant or $50,000 for a collaborative grant – indirect costs are not allowed)
e. Biographical Sketch(es) for key personnel
f. Resources
g. Checklist
4) Research Plan to include (limited to 5 pages):
a. State whether you are applying for an individual grant of $25,000 or a collaborative grant of $50,000 (collaborative grants must demonstrate collaborative work between at least two mental health research institutions in Arizona).
b. Specific Aims
c. Background and Significance. Clearly state how the research relates to mental health issues
d. Preliminary Studies
e. Research Design and Methods. Make explicit what pilot data will be obtained if requested funds are awarded.
f. Timeline and Plan for Submission of Competitive Grant Application
g. Human Subjects (if applicable)
h. Vertebrate Animals (if applicable)
i. Literature Cited
5) Appendices are limited to two publications, manuscripts, abstracts, patents, or other printed materials directly relevant to the proposal.

SUBMIT APPLICATION: Email the entire application as one file, appendices can be in a separate file in the same email to: http://www.firedrummarketing.com/servlet/clickercount?clientid=00000203&messageid=00001106&memberid=01322706&sendingid=560FBFB751D5&campaignid=00001106&finaldest=mailto:Clagesse@imhr.org. Mail the original signed application to:Carol Lagesse, Operations DirectorInstitute for Mental Health Research222 W. Thomas Road, Suite 414Phoenix, AZ 85013

APPLICATION REVIEW CRITERIA: Applications will be reviewed for scientific and technical merit by Internal and External Scientific Advisors. Applications will be rated based on 1) significance, 2) quality, innovation, and feasibility, 3) use of existing facilities, 4) potential of applicant to develop a successful research program in the field, 5) likelihood of leading to a successful grant application from another source or commercial potential, and 6) compatibility with IMHR’s statewide mental health vision and mission. Final award decisions will be made by the Board of Directors of IMHR in January 2008. Notification of Awards will be available no later than January 31, 2008. The expected funding start date of successful applications will be March 3, 2008.

INQUIRIES: Inquiries are encouraged and can be directed to:Carol Lagesse, Operations DirectorInstitute for Mental Health Research222 W. Thomas Road, Suite 414Phoenix, AZ 85013Email: http://www.firedrummarketing.com/servlet/clickercount?clientid=00000203&messageid=00001106&memberid=01322706&sendingid=560FBFB751D5&campaignid=00001106&finaldest=mailto:Clagesse@imhr.orgPhone: 602.406.4360

BioAgriculture Small Business Innovation Research

The purpose of the SBIR program is to provide an opportunity for US-owned, for-profit small business firms to submit innovative, applied, research and development projects that address important problems facing American agriculture and have the potential to lead to significant public benefit if the research is successful. Research proposals are accepted in any of the following topic areas: 1) Forests and Related Resources; 2) Plant Production and Protection - Biology; 3) Animal Production and Protection; 4) Soil and Water Resources; 5) Food Science and Nutrition; 6) Rural Development; 7) Aquaculture; 8) Biofuels and Biobased Products; 9) Marketing and Trade; 10) Animal Manure Management; 11) Small and Mid-Size Farms; and 12) Plant Production and Protection - Engineering. The SBIR program exists in three phases. The purpose of Phase I is to prove the scientific or technical feasibility of the proposed research and development effort. Phase I projects typically are for 8 months. Phase II is the principal research and development effort and often involves moving the project from the laboratory to the field or the development of prototypes. Phase II projects typically are for 24 months. Phase III is the commercialization phase and there is no SBIR support provided for this phase. Phase I applications are due on September 5, 2007. This SBIR program funding opportunity is for Phase I applications.

Link to Full Announcement
Fiscal Year 2008 Small Business Innovation Research Program - Phase I
If you have difficulty accessing the full announcement electronically, please contact:
CSREES Help Desk Phone: 202-401-5048 Business hours are M-F, 7:00 am -5:00 pm ET, excluding Federal holidays If you have any questions related to preparing application content

Reporting DNA-Based Genetic Test Results Applicable to Heritable Conditions and/or Markers of Drug Metabolism

The purpose of this RFA is to solicit applications proposing to develop and pilot test genetic test reports designed to integrate genotypic results pertinent to heritable conditions and/or markers for drug metabolism into a clear and coherent interpretation that effectively communicates clinically important concepts useful for clinical decision making and/or counseling.
Link to Full Announcement
CDC Grant Funding Opportunity Announcements (FOAs)
If you have difficulty accessing the full announcement electronically, please contact:
CDC, Technical Information Management Section Phone 770-488-2700 Procurement and Grants Office, Technical Information Management Section

Neurotechnology Research, Development, and Enhancement (SBIR [R43/R44]) and SSTR

Advances in the brain and behavioral sciences are being made rapidly, vastly improving our understanding of healthy brain function and offering promise to the millions suffering from brain and behavioral disorders. This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to enable neuroscience and behavioral research through the development of novel, or the significant enhancement or improvement of currently existing, tools and approaches to be used in brain and behavioral research. Such tools and approaches could include those used in basic or clinical research, or for clinical treatment and care (e.g., assessment, diagnosis, and treatment of brain disorders). Research solicited under this funding opportunity announcement is not limited to any particular type of technology, level of analysis, or approach. Multidisciplinary teams of researchers are especially encouraged to apply. Technologies appropriate for study, development and enhancement under this FOA include hardware, software, and wetware (and combinations thereof).
Link to Full Announcement
http://grants.nih.gov/grants/guide/pa-files/PA-07-389.html
If you have difficulty accessing the full announcement electronically, please contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOVIf you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Reducing Health Disparities Among Minority and Underserved Children (R01)

This Funding Opportunity Announcement (FOA) issued by the National Institute of Nursing Research (NINR), National Institute of Child Health and Human Development (NICHD), National Heart, Lung, and Blood Institute (NHLBI), National Institute on Alcohol, Alcoholism, and Alcohol Abuse (NIAAA), National Cancer Institute (NCI), and National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), solicits Research Project Grant (R01) applications from institutions/organizations that propose to conduct research to reduce health disparities among minority and underserved children. Specifically, this initiative focuses on ethnic and racial minority children and underserved populations of children such as: children from low literacy, rural and low-income populations, geographically isolated children, hearing and visually impaired children, physically or mentally disabled children, children of migrant workers, children from immigrant and refugee families, and language minority children. Specific targeted areas of research include biobehavioral studies that incorporate multiple factors that influence child health disparities such as biological (e.g., genetics, cellular, organ systems), lifestyle factors, environmental (physical and family environments), social (e.g., peer influences), economic, institutional, and cultural and family influences; studies that target the specific health promotion needs of children with a known illness and/or disability; and studies that test and evaluate the cost effectiveness of health promotion interventions conducted in nontraditional settings
Link to Full Announcement
http://grants.nih.gov/grants/guide/pa-files/PA-07-392.html
If you have difficulty accessing the full announcement electronically, please contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOVIf you have any problems linking to this funding announcement, please contact the NIH OER Webmaster